Proteome Sciences plc (LON:PRM) insider Martin Diggle acquired 256,520 shares of the firm’s stock in a transaction that occurred on Wednesday, October 18th. The stock was acquired at an average price of GBX 3 ($0.04) per share, for a total transaction of £7,695.60 ($10,225.35).

Martin Diggle also recently made the following trade(s):

  • On Friday, October 20th, Martin Diggle acquired 119,636 shares of Proteome Sciences plc stock. The stock was acquired at an average price of GBX 3 ($0.04) per share, for a total transaction of £3,589.08 ($4,768.91).

Proteome Sciences plc (LON:PRM) traded up 2.21% during midday trading on Monday, hitting GBX 3.24. 311,904 shares of the company traded hands. The stock has a 50 day moving average of GBX 3.49 and a 200 day moving average of GBX 4.18. Proteome Sciences plc has a 12-month low of GBX 2.61 and a 12-month high of GBX 11.12. The stock’s market cap is GBX 9.54 million.

ILLEGAL ACTIVITY WARNING: This news story was first posted by American Banking News and is the property of of American Banking News. If you are accessing this news story on another site, it was copied illegally and reposted in violation of United States and international trademark & copyright laws. The legal version of this news story can be read at

Separately, FinnCap reiterated a “corporate” rating and issued a GBX 12 ($0.16) price objective on shares of Proteome Sciences plc in a research report on Tuesday, July 25th.

About Proteome Sciences plc

Proteome Sciences plc is a protein biomarker company specializing in proteomics and peptidomics services and applications, and mass spectrometry (MS) protein analysis. The Company is engaged in biomarker research and development in applied proteomics and workflows using its techniques to detect and characterize differentially expressed proteins in diseases for diagnostic, prognostic and therapeutic applications.

Insider Buying and Selling by Quarter for Proteome Sciences plc (LON:PRM)

Receive News & Ratings for Proteome Sciences plc Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Proteome Sciences plc and related companies with's FREE daily email newsletter.